- Senior Research Fellow (Institute of Cardiovascular and Medical Sciences)
- Associate - Life Sciences (School of Life Sciences)
Bill Mullen is a Research Fellow for the Institute of Cardiovascular & Medical Sciences at the University of Glasgow. He returned to the University after working in a Pharmaceutical Drug Metabolism lab and also running his own company designing and manufacturing scientific instruments for metabolite analysis. Since returning to the University in 1998 he has published more than 60 manuscripts in peer reviewed journals. His first 10 years back at the University was in the Plant Products and Human Nutrition group, where his expertise in mass spectrometric analysis became world renowned. His principle aim was to find causal links between diet and health. We all know that a diet rich in fruit and vegetables is good for us, but why? It became apparent to him that the classical bioavailability/ metabolism approach to this question was not going to reveal the answer. The chance to work with Harald Mischak in applied systems biology, with the latest Orbitrap mass spectrometer, was too good an offer to turn down. Although the primary goal of the group is generating peptide “fingerprints” of disease to allow early diagnosis and monitoring of treatment, this work would lend itself to his original question of why fruit and vegetables are needed for a healthy life. By being able to determine deterioration in health as such an early stage, that no lasting damage had incurred, he believes it may be possible to show changes in diet could alter the biomarker fingerprints from unhealthy to healthy.
Grants and Awards listed are those received whilst working with the University of Glasgow.
- Metabolite and protein profiling in CADASIL to unravel the vascular pathophysiology and natural history
NHS Endowment Funds
2014 - 2016
2014 - 2018
- Urine proteomics as biomarker for inflammatory arthritis
Pfizer Global Research and Development
2013 - 2014
- Can a football-based weight management, physical activity and healthy living programme be adapted for delivery in secure institutional settings to support at risk groups in positive, sustainable ....
Scottish Executive Health Department
2013 - 2015
- Bioavailability of Olive Oil phenolics and impact of high olive oil consumption on proteomic markers
University of Lisbon
2012 - 2015
- The iomarkers in Stroke Programme; Detecting, Understanding, and Predicting Outcome After Stroke (ISSF Catalyst Fund)
2011 - 2014
- Investigating the potential of cathepsin-L as a common therapeutic target and biomarker for coronary heart disease and African trypanosomiasis (ISSF Catalyst Fund)
2011 - 2014